Investigating the tissue specificity and prognostic impact of cis-regulatory cancer risk variants

Hum Genet. 2023 Sep;142(9):1395-1405. doi: 10.1007/s00439-023-02586-6. Epub 2023 Jul 20.

Abstract

The tissue-specific incidence of cancers and their genetic basis are poorly understood. Although prior studies have shown global correlation across tissues for cancer risk single-nucleotide polymorphisms (SNPs) identified through genome-wide association studies (GWAS), any shared functional regulation of gene expression on a per SNP basis has not been well characterized. We set to quantify cis-mediated gene regulation and tissue sharing for SNPs associated with eight common cancers. We identify significant tissue sharing for individual SNPs and global enrichment for breast, colorectal, and Hodgkin lymphoma cancer risk SNPs in multiple tissues. In addition, we observe increasing tissue sharing for cancer risk SNPs overlapping with super-enhancers for breast cancer and Hodgkin lymphoma providing further evidence of tissue specificity. Finally, for genes under cis-regulation by breast cancer SNPs, we identify a phenotype characterized by low expression of tumor suppressors and negative regulators of the WNT pathway associated with worse freedom from progression and overall survival in patients who eventually develop breast cancer. Our results introduce a paradigm for functionally annotating individual cancer risk SNPs and will inform the design of future translational studies aimed to personalize assessment of inherited cancer risk across tissues.

MeSH terms

  • Genetic Predisposition to Disease
  • Genome-Wide Association Study*
  • Hodgkin Disease*
  • Humans
  • Organ Specificity / genetics
  • Polymorphism, Single Nucleotide
  • Prognosis